Towa Corp (TSE: 6315) is a Kyoto maker of semiconductor back-end equipment. It is put at 60–70% global share in molding (encapsulation) systems — the resin-sealing step behind HBM stacking and advanced packaging (note: it is a different company from the drugmaker Towa Pharmaceutical, 4553). FY3/2026 delivered record revenue but net profit fell 43%, and its May guidance came in below market expectations, drawing disappointment selling. The stock fell from a year-to-date high of ¥3,735 on July 1, 2026 to ¥2,791 on July 17 (down 11.82% that day) in the semiconductor sell-off. This page summarizes the board talking points as of July 2026, the business and AI-cycle position, and how to read the stock.
▶ Browse the futures markets on WEEX ・ Yahoo Finance Japan board (6315)
On July 17, 2026 the Nikkei fell 4.03% to 64,141 on a US-led semiconductor decline, and AI and chip names were sold. Towa dropped 11.82% the same day. Themes observed on the board:
Founded in 1979 as Towa Seimitsu Kogyo and renamed Towa in 1988, the company is a Kyoto maker of semiconductor back-end equipment (TSE machinery sector, headquartered in Kyoto). Its core products are molding systems that seal chips in resin, plus precision molds; the Japanese Wikipedia entry cites 60–70% global share. Compression molding in particular is described as yield-critical for HBM stacking and chiplet packaging, and is said to be used in AI-chip mass production — though this page does not confirm any specific customer names.
FY3/2026 results (announced May 11, 2026): revenue of ¥54.37 billion (+1.7%, a record on AI-datacenter orders), but operating profit of ¥6.92 billion (−22.1%), recurring profit of ¥6.95 billion (−26.1%) and net profit of ¥4.59 billion (−43.4%). Management attributed the margin pressure to product mix and one-off first-delivery costs for new compression tools. The FY3/2027 plan guides recurring profit of ¥10.24 billion (+47.4%) — a big rebound, but below the market's roughly ¥12.5 billion, which drew disappointment selling at the May release.
The shares ran from a year-to-date low of ¥2,181 on March 31, 2026 to a year-to-date high of ¥3,735 on July 1, then closed at ¥2,791 on July 17 (down 11.82% that day, about 25% off the high). That leaves a forward P/E near 29.9x, a PBR of 2.97x and a yield of 0.86%, all at the July 17, 2026 price. Note that a 1-to-3 stock split took effect on October 1, 2024, so earlier prices must be divided by three to compare. Bulls point to a 60–70% back-end chokepoint, strong orders, and an INNOMS-driven margin fix that would make the +47% recurring-profit plan credible. Bears note that guidance already sits below consensus, that net profit fell 43% in an AI-boom year, that China is roughly 39% of FY3/2026 sales (as reported), and that a 25% drop in three weeks signals crowding. This page sets no price target.
The AI and semiconductor cycle that drives Towa is a global theme, expressed most directly in US chip names such as NVIDIA (NVDA). To own Towa shares themselves, the standard route is a Japanese brokerage account. On WEEX you can trade NVDA via futures (leverage, long or short) or on the spot market, alongside tokenized US semiconductor products such as AMDON, MUON, ARMON, INTCON and SNDKON. Tokenized stocks are not the underlying shares; they are tracking products that follow the reference stock's price. See the NVIDIA (NVDA) guide and the WEEX market listings. WEEX offers crypto and tokenized US equities — not Towa or any other Japanese stock, nor any proxy for them.
On the Yahoo Finance Japan board (6315), where retail investors discuss the stock and price.
No. Towa Corp (6315, Kyoto), the semiconductor-equipment maker, is a different company from the drugmaker Towa Pharmaceutical (4553). The similar names are easy to confuse.
It is a 60–70% global-share leader in a back-end AI-packaging step, yet net profit fell 43% and the stock is down about 25% from its high.
Q1 results are expected in late July to August 2026, but the date should be confirmed on the company's IR page (not yet fixed as of this writing).
AI-packaging orders, new products such as INNOMS and their margins, quarterly results, the China sales share, and the overall semiconductor sector mood.
This article is for information only and is not investment advice; nothing here is a recommendation to buy or sell.
This content is provided for general informational purposes only and doesn't constitute financial, investment, legal, or tax advice. Any events, rewards, online promotions, or related information mentioned herein should not be considered a recommendation, solicitation, or invitation to purchase, sell, trade, or otherwise deal in any crypto assets. Crypto assets are highly volatile and may result in loss. The availability of WEEX services, products, and related events may vary by region. You are responsible for ensuring that your participation is in accordance with applicable local laws and regulations.





























